Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Here's Why Axsome Therapeutics Fell 20.4% in the First Half of 2020
06:41pm, Wednesday, 08'th Jul 2020
One of the best investments of 2019 fell on hard times in the first six months of 2020, but it's not as bad as it seems.
3 “Perfect 10” Healthcare Stocks That Have Plenty of Growth on Tap
03:14pm, Tuesday, 07'th Jul 2020
Disconnected. This seems to be the best way to describe the current economic environment. Amid high levels of unemployment and tanking earnings, stocks aren’t just hanging in there, they’re chargi
What Kind Of Investors Own Most Of Axsome Therapeutics, Inc. (NASDAQ:AXSM)?
07:19pm, Friday, 03'rd Jul 2020
A look at the shareholders of Axsome Therapeutics, Inc. (NASDAQ:AXSM) can tell us which group is most powerful...
Axsome Therapeutics Inc (NASDAQ:AXSM) Director Purchases $51,025.00 in Stock
06:44am, Thursday, 02'nd Jul 2020
Axsome Therapeutics Inc (NASDAQ:AXSM) Director Mark Coleman purchased 650 shares of the stock in a transaction on Monday, June 29th. The shares were purchased at an average cost of $78.50 per share, f
Voloridge Investment Management LLC Acquires Shares of 7,285 Axsome Therapeutics Inc (NASDAQ:AXSM)
09:13am, Wednesday, 01'st Jul 2020
Voloridge Investment Management LLC acquired a new stake in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange
Axsome's AXS-05 Gets Breakthrough Therapy Tag for AD Agitation
04:49pm, Monday, 29'th Jun 2020
The FDA bestows a Breakthrough Therapy status on Axsome's (AXSM) AXS-05 for the treatment of Alzheimer's disease agitation. Shares rise.
Why Axsome Therapeutics Stock Is Sinking Today | The Motley Fool
04:45pm, Monday, 29'th Jun 2020
Some traders appear to be taking profits off the table after the stock's jump last week.
Why Axsome Therapeutics Stock Is Jumping Today | The Motley Fool
03:44pm, Friday, 26'th Jun 2020
The drugmaker received good news from the FDA for one of its pipeline candidates.
Axsome Therapeutics Receives FDA Breakthrough Therapy Designation for AXS-05 for the Treatment of Alzheimer’s Disease Agitation
11:00am, Friday, 26'th Jun 2020
Axsome Therapeutics, Inc. (AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that the U.S. Food and Drug Admin
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
12:00am, Friday, 26'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 25)
Brainstorm Cell...
Two Sigma Advisers LP Has $6.95 Million Position in Axsome Therapeutics Inc (NASDAQ:AXSM)
07:38am, Tuesday, 23'rd Jun 2020
Two Sigma Advisers LP increased its stake in Axsome Therapeutics Inc (NASDAQ:AXSM) by 342.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 118,100
Axsome Looks Extremely Undervalued After Recent Share Price Decline
08:23pm, Sunday, 21'st Jun 2020
Axsome is planning to submit NDAs later this year for its 2 leading indications. These 2 indications alone have projected peak sales up to $3 billion, but Axsom
Alliancebernstein L.P. Grows Stake in Axsome Therapeutics Inc (NASDAQ:AXSM)
07:30am, Thursday, 18'th Jun 2020
Alliancebernstein L.P. grew its position in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) by 11.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Comm
3,800 Shares in Axsome Therapeutics Inc (NASDAQ:AXSM) Purchased by AlphaCrest Capital Management LLC
07:58am, Tuesday, 16'th Jun 2020
AlphaCrest Capital Management LLC purchased a new position in shares of Axsome Therapeutics Inc (NASDAQ:AXSM) in the 1st quarter, Holdings Channel reports. The institutional investor purchased 3,800 s
